Skip to main content

Advertisement

Log in

Association of incidence of type 1 diabetes with mortality from infectious disease and with antibiotic susceptibility at a country level

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

To investigate the association between country incidence of type 1 diabetes and mortality from infectious disease and antibiotic susceptibility. An ecological study to explore the relationship at a country level of the reported incidence of type 1 diabetes (DiaMond) to infectious disease mortality (World Health Organisation) and to antibiotic susceptibility (Alexander Project). There were significant negative correlations between the incidence of type 1 diabetes and mortality for all infectious diseases studied. There were also significant positive correlations between the incidence of type 1 diabetes and antibiotic susceptibilities of Strep. pneumoniae, but not to those of Haem. influenzae. Since infectious disease mortality and antibiotic susceptibility are surrogate markers for bacterial exposure, our results provide support for a negative association between bacterial exposure in a community and its incidence of type 1 diabetes. The consistency of our results as well as the highly statistically significant results of most of the associations studied reinforces the validity of our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Skrivarhaug T, Bangstad HJ, Stene LC et al (2006) Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 49:298–305

    Article  PubMed  CAS  Google Scholar 

  2. Dahlquist G, Kallen B (2005) Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care 28:2384–2387

    Article  PubMed  Google Scholar 

  3. Törn C, Ingemansson S, Lindblad et al. DISS study group (2011) Excess mortality in middle-aged men with diabetes aged 15–34 years at diagnosis. Acta Diabetol 48(3):197–202. doi: 10.1007/s00592-011-0272-2

  4. Gale EA (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361

    Article  PubMed  CAS  Google Scholar 

  5. Harrison LC, Honeyman MC, Morahan G et al (2008) Type 1 diabetes: lessons for other autoimmune diseases? J Autoimmun 31:306–310

    Article  PubMed  CAS  Google Scholar 

  6. Fsadni P, Fsadni C, Fava S, Montefort S (2012) Correlation of worldwide incidence of type 1 diabetes (DiaMond) with prevalence of asthma and atopic eczema (ISAAC). Clin Respir J 6:18–25

    Article  PubMed  Google Scholar 

  7. Christen U, von Herrath MG (2005) Infections and autoimmunity: good or bad? J Immunol 174:7481–7486

    PubMed  CAS  Google Scholar 

  8. D’Angeli MA, Merzon E, Valbuena LF, Tirschwell D, Paris CA, Mueller BA (2010) Environmental factors associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and overload hypotheses. Arch Pediatr Adolesc Med 164(8):732–738

    Article  PubMed  Google Scholar 

  9. Airaghi L, Tedeschi A (2006) Negative association between occurrence of type 1 diabetes and tuberculosis incidence at population level. Acta Diabetol 43:43–45

    Article  PubMed  CAS  Google Scholar 

  10. Cardwell CR, Carson DJ, Patterson CC (2008) No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database. Diabet Med 25(3):261–267

    Article  PubMed  CAS  Google Scholar 

  11. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tumilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 10:1516–1526

    Article  Google Scholar 

  12. Mathers CD, Bernard C, Iburg K, Inoue M, Ma Fat D, Shibuya K, Stein C, Tomijima, N (2003). The Global Burden of Disease in 2002: data sources, methods and results. Geneva, World Health Organization (GPE Discussion Paper No. 54). Available at http://www.who.int/evidence. Accessed 30/1/12

  13. World Health Organization. World Health Report 2004: changing history. Available at http://www.who.int/whr. Accessed 30/1/12

  14. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN and the Alexander Project Group (2003) The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antmicrob Chemother 52: 229–246

    Google Scholar 

  15. The EuroDiab Investigators (2000) Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB Substudy 2 Study Group. Diabetologia 43:47–53

    Article  Google Scholar 

  16. Brugman S, Klatter FA, Visser JT et al (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49(9):2105–2108

    Article  PubMed  CAS  Google Scholar 

  17. Buschard K, Pedersen C, Hansen SV, Hageman I, Aaen K, Bendtzen K (1992) Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats. Autoimmunity 14:101–104

    Article  PubMed  CAS  Google Scholar 

  18. Hviid A, Svanström H (2009) Antibiotic use and type 1 diabetes in childhood. Am J Epidemiol 169(9):1079–1084

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen Fava.

Additional information

Communicated by Renato Lauro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abela, AG., Fava, S. Association of incidence of type 1 diabetes with mortality from infectious disease and with antibiotic susceptibility at a country level. Acta Diabetol 50, 859–865 (2013). https://doi.org/10.1007/s00592-013-0464-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-013-0464-z

Keywords

Navigation